Andromeda by Eureka Seeds Org: A Comprehensive Strain Guide

Overview and Naming

Andromeda is a hybrid cannabis cultivar developed by Eureka Seeds Org, positioned as an indica/sativa selection that marries vigor with a modern resin-forward chemotype. The name evokes the Andromeda galaxy, signaling both a sprawling aroma bouquet and a luminous trichome sheen that growers often remark upon. In practice, it behaves like a balanced hybrid with slight indica-leaning structure, yet energizing top notes often surface depending on phenotype and harvest timing.

Because Andromeda shares its name with other breeder lines and derivative projects in public genealogy databases, it is important to anchor this profile to the Eureka Seeds Org release. This version emphasizes dense, frost-heavy flowers, a sweet-to-spicy terpene stack, and commercially viable yields that do not require extreme feeding. For consumers, the strain offers a versatile experience that can be steered toward daytime or evening by dose, terpene dominance, and cure.

Across different markets, Andromeda has earned a reputation as a flexible cultivar that responds well to training and canopy management. Indoor cultivators praise its predictable 1.5–2.0x stretch and straightforward nutritional needs. Consumers often note a clean finish on the palate and a balanced arc of effects that build steadily without the sharp onset some high-THC varieties can deliver.

History and Breeding Background

Eureka Seeds Org bred Andromeda as a contemporary hybrid in the indica/sativa tradition, aiming for a resinous flower with robust structure and adaptable canopy behavior. While the breeder has not formally published a full parentage breakdown, the emphasis appears to be on selecting for uniform internodal spacing and a terpene profile that balances fruit, citrus, and spice. This approach is consistent with industry movement over the past decade toward hybrids that achieve dispensary-ready bag appeal without sacrificing grower-friendly vigor.

In consumer markets from 2018 onward, hybrids with total terpene content of 1.5–3.0% by weight and THC in the 18–26% range have dominated shelf space. Andromeda fits neatly within this band, giving it broad appeal for both connoisseurs and occasional users. The strain’s positioning aligns with a data-backed trend: in U.S. adult-use markets, the median THC of top-selling flower lots tracked between 20–22% from 2020–2023, with hybrid chemovars leading unit sales.

The Andromeda name has surfaced in other breeding contexts, which sometimes confuses lineage discussions online. Eureka’s Andromeda should be distinguished from unrelated projects carrying the “Andromeda” or “Andromeda Strains” label. The Eureka selection is identifiable by its balanced indica/sativa heritage, stable stretch characteristics, and a terpene axis often led by myrcene, limonene, and beta-caryophyllene.

Genetic Lineage and Related Strains

Eureka Seeds Org lists Andromeda as an indica/sativa hybrid but has not publicly disclosed the exact cross, a common practice for protecting proprietary lines. What is known from grower reports is that Andromeda presents two recurring phenotypes: one broader-leafed, slightly shorter plant with tighter node spacing, and one taller, more sativa-leaning expression with longer internodes. Both phenotypes tend to converge on similar terpene clusters and finish within a 56–65 day flowering window under typical indoor conditions.

Public genealogy resources sometimes show “Andromeda Strains” as a breeder tag within complex crosses and derivative projects, creating name overlap. For example, the Original Strains’ “Unknown Strain Lineage & Hybrids” listing includes Dutch Yeti OG framed as {Dutch Treat (Jordan of the Islands) x Cherry Sauce (Andromeda Strains)} x Unknown Strain (Original Strains). This snippet illustrates how the “Andromeda” name appears in broader breeding ecosystems, but it does not define Eureka Seeds Org’s Andromeda lineage directly.

Given the lack of a published pedigree, it is most accurate to position Andromeda as a modern hybrid selected for high trichome density, mid-range stretch, and a fruit-spice aromatic spectrum. Its behavior under lights and its chemical profile place it near popular “Cookie/Kush with citrus” style hybrids, though growers should expect Andromeda to root faster and feed slightly lighter than many OG-derived lines. Until a formal family tree is disclosed, horticultural performance and lab results provide the clearest windows into its heritage.

Morphology and Appearance

Andromeda typically grows with medium vigor and a balanced architecture that readily adapts to topping, low-stress training (LST), and screen-of-green (ScrOG) layouts. Expect a 1.5–2.0x stretch after the flip to 12/12, which makes it easy to fill a net without overrunning vertical space. Internode spacing lands in the moderate range, enabling good airflow without sacrificing collation of dense flower sites.

The flowers themselves are compact and resin-heavy, showing a high calyx-to-leaf ratio that simplifies trimming. Mature buds often exhibit lime to forest-green hues freckled by copper to rose-colored pistils, with occasional lavender flecks if night temperatures drop 3–5°C late in flower. Trichome coverage is conspicuously thick, and cured nuggets take on a sugared look reminiscent of frost-dusted grapes.

Under adequate PPFD, calyxes swell into firm, granular structures with minimal foxtailing, provided daytime canopy temperatures remain in the 22–26°C range during mid-to-late bloom. Stems are sturdy enough to support weight but benefit from trellising in week 3–5 of flower for even colas. In high-terp phenos, bract tips can get tacky by week 6, a good visual cue that harvest is approaching within two weeks.

Aroma and Bouquet

The dominant aromatic thread in Andromeda combines ripe stone fruit and sweet citrus with a scaffold of peppery spice and woodland herb. Many growers report a top note reminiscent of candied grapefruit or tangerine, layered over apricot or white peach. Beneath that brightness, expect beta-caryophyllene to contribute a black-pepper warmth and faint clove-like undertone.

When the jar opens, the first impression is often sweet and clean, followed by a musky, earthy pulse anchored by myrcene and humulene. On the grind, lime zest and resinous pine jump forward, likely tied to limonene and alpha-pinene. After a week or two of cure, the bouquet smooths out, and the herbal components knit into a coherent profile that reads as fruit-forward with a spicy finish.

In rooms with good environmental control, total terpene content often concentrates in the 1.6–2.8% range by weight, which is solidly above average for commercial flower. High-airflow dries can volatilize monoterpenes, so a slow cure at 58–62% relative humidity preserves limonene and myrcene while letting caryophyllene and linalool add polish. The result is a nose that remains expressive for months if stored in cool, dark conditions.

Flavor and Mouthfeel

Andromeda’s flavor mirrors its aromatics, opening with sweet citrus—think tangerine candy or preserved lemon—before resolving into peach skin, pine resin, and a peppered herbal snap. Vaporized at 175–190°C, many users notice clarified notes of apricot nectar and lemongrass. Through combustion, the spice and pine become more pronounced, and the finish leans drier with a whisper of clove.

The mouthfeel is medium-bodied and clean, lacking the heavy, oily density common to some Kush expressions. The inhale is smooth when the cure is patient and chlorophyll is allowed to off-gas fully over 14–21 days. On the exhale, citrus esters pop, followed by a cooling pine and black pepper tail that lingers without harshness.

Flavor retention remains strong across multiple pulls, suggesting a balanced monoterpene-to-sesquiterpene ratio. Anecdotally, rosin pressed from Andromeda at 85–90°C yields a bright citrus-spice flavor that holds through low-temp dabs. For edibles, the cultivar’s zest and stone-fruit tones translate well into pastry and chocolate matrices, masking “green” notes better than more diesel-forward cultivars.

Cannabinoid Profile and Potency

Andromeda is a Type I chemovar (THC-dominant) with typical total THC content ranging between 18–26% in well-grown indoor flower. In normalized lab data across hybrid-dominant retail lots from 2021–2024, the median THC for top-tier batches in legal U.S. markets has hovered near 21–22%, and Andromeda commonly falls within this bracket. Lower-nitrogen, high-light environments tend to push potency up by 1–2 percentage points, especially when harvest timing coincides with peak cloudiness of trichome heads.

CBD is generally trace, often 0.05–0.3%, keeping the THC:CBD ratio well above 20:1. Minor cannabinoids such as CBG can show more variability, with 0.2–1.2% totals reported depending on phenotype and maturity. When grown under high PPFD and optimal DLI, CBG values trend higher, a pattern often attributed to robust primary metabolism translating to stronger precursor pools.

For concentrates, Andromeda’s trichome density supports good extraction metrics. Hydrocarbon extracts commonly show total cannabinoid figures of 70–85%, while mechanically separated rosin often returns 18–25% by weight from high-grade fresh frozen material. These figures depend on harvest window, biomass moisture, and press parameters, but the cultivar’s resin head size and abundance are generally favorable for yield and flavor.

Users should consider potency management with dose titration, as the balanced head-to-body effects can shift toward sedation at higher THC loads. For inhalation, first-time consumers often start at 1–2 inhalations (approximately 2–5 mg THC estimated) and wait 10–15 minutes before redosing. For edibles derived from Andromeda, typical microdosing bands of 1–2.5 mg THC help gauge sensitivity before moving toward 5–10 mg servings.

Terpene Profile and Minor Aromatics

The leading terpene triad in Andromeda is frequently myrcene, limonene, and beta-caryophyllene, with supportive roles from alpha-pinene, humulene, and linalool. Total terpene percentages of 1.6–2.8% by weight are common in dialed-in rooms, with the dominant terpene typically holding 0.4–1.0% individually. This distribution produces a fruit-citrus top, a peppered backbone, and enough pine and floral accents to keep the bouquet dynamic.

Myrcene contributes to the musky, ripe fruit undertones and can synergize with THC to produce heavier body sensations at higher doses. Limonene drives the candied citrus and may correlate with mood-elevating effects reported in survey research on citrus-dominant chemovars. Beta-caryophyllene, a dietary terpene that binds to CB2 receptors, brings spice and is often discussed in the context of inflammation-modulating potential in preclinical studies.

Supporting terpenes shape the edges of Andromeda’s profile. Alpha-pinene offers resinous pine and may attenuate short-term memory disruption in THC contexts according to experimental models, while humulene adds a dry, woody snap. Linalool, even at modest levels (0.05–0.2%), tends to round the finish with a faint lavender-like softness that many consumers perceive as calming.

In sensory testing, the profile often slots into a “citrus-fruit spice” cluster rather than the gassy-diesel or floral-berry families. This makes Andromeda distinct on a dispensary menu and helps it pair well in blends where a brighter top note is desired without overwhelming skunk volatiles. Careful dry and cure practices preserve the more volatile monoterpenes that define its signature nose.

Experiential Effects and Use Patterns

Andromeda’s effects typically begin with a clear, mood-forward onset within 2–10 minutes of inhalation, depending on lung volume, device, and individual tolerance. Many users report a warm lift in outlook and sensory acuity that transitions into a centered, body-easing calm over 30–45 minutes. The balanced arc makes it suitable for creative tasks, social sessions, or evening decompression, with sedation rising mainly at higher doses or later in the effect window.

Duration for inhaled use usually spans 2–4 hours, with the plateau shifting longer for individuals with slower metabolism or when consumed alongside food. Edible formats extend the window to 4–8 hours, and the body load becomes more pronounced as 11-hydroxy-THC circulates. For most, the cultivar does not deliver the raciness associated with narrow-leaf dominant sativas, though high doses can produce transient anxiety in sensitive users as with any high-THC chemovar.

Commonly cited effects include uplifted mood, tactile comfort, and a light to moderate euphoria that doesn’t crowd focus unless one exceeds their dose comfort zone. Microdosing supports daytime functionality, while higher nighttime doses can lead to a soothing heaviness suitable for winding down. Survey data across large user bases for citrus-forward hybrids often show improvements in stress (50–70% reported reduction) and minor aches (40–60% reported reduction), figures that align with anecdotal reports around Andromeda.

Side effects tend to be the usual suspects: dry mouth and eyes occur in roughly 20–35% of users based on self-report datasets, with occasional dizziness or transient anxiety noted in 5–15% at elevated doses. Staying hydrated, pacing inhalations, and avoiding stacking alcohol can mitigate these issues. As always, individual responses vary widely, and starting low and going slow remains sound practice.

Potential Medical Applications

Because Andromeda is THC-dominant with a myrcene–limonene–caryophyllene core, it is often explored for stress modulation, mood support, and body discomfort. In app-based observational studies of cannabis use, citrus-leaning hybrids show user-reported reductions in anxiety and stress, often in the 40–70% range. Myrcene’s association with muscle relaxation and caryophyllene’s CB2 activity offer plausible mechanisms for perceived relief in minor pain and tension.

Sleep applications arise when Andromeda is dosed toward the higher end, especially if the phenotype has a stronger myrcene presence. Users commonly report easier sleep onset and improved sleep continuity when dosing 60–90 minutes before bedtime, though tolerance and paradoxical stimulation can complicate results. Linalool and humulene, when present, may add a calming nudge that some find helpful in evening routines.

For mood, limonene-dominant expressions are frequently chosen by individuals experiencing low energy or situational blues. While rigorous clinical trials on specific strains are limited, broader literature on limonene inhalation suggests potential anxiolytic and mood-brightening effects in animal and small human studies. As a THC-rich product, Andromeda also engages the endocannabinoid system broadly, which many patients leverage for appetite stimulation.

People with inflammatory complaints sometimes select beta-caryophyllene forward flower, given preclinical evidence of CB2-mediated inflammation modulation. However, outcomes are highly individualized, and medical guidance is advisable, especially for those with comorbid conditions or on interacting medications. Start at low doses, track responses, and consider terpene-dominance when selecting batches to align effects with personal goals.

Cultivation Guide: Environment, Nutrition, and Training

Andromeda is forgiving and productive when environmental basics are dialed. Indoors, target day temperatures of 24–28°C in vegetative growth and 22–26°C in flower, with night drops of 2–4°C to enhance color and terpene retention. Relative humidity should progress from 65–70% for seedlings, 55–65% in veg, 45–55% in early flower, and 40–50% in late flower to keep VPD in the 0.8–1.1 kPa (veg) and 1.2–1.5 kPa (bloom) ranges.

Light intensity responds best at PPFD of 700–900 µmol/m²/s in veg and 900–1,100 µmol/m²/s in bloom, translating to DLI targets near 35–45 mol/m²/day (veg) and 45–55 mol/m²/day (bloom). Monitor leaf temperature with an IR gun; keep leaf surface wit